ACT Advisors’s Mangoceuticals MGRX Stock Holding History

ACT Advisors’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.27K	Sell	12,314 -14,549	-54%	-$6.45K	﹤0.01%	85
2026 Q2	$10.2K	Buy	+26,863	New	+$10.4K	﹤0.01%	81

Other funds holding MGRX

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

ACT Advisors's MGRX Position: Q3 2026 in Review

ACT Advisors reduced its Mangoceuticals (MGRX) stake by 54% in Q3 2026, selling an estimated $6.45K and leaving 12,314 shares worth $5.27K. The position accounts for ﹤0.01% of the portfolio, ranked #85.

ACT Advisors first reported a position in MGRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $10.2K in Q2 2026. 2 funds tracked by Wall St. Rank hold MGRX as of Q3 2026.

ACT Advisors held 12,314 shares of Mangoceuticals worth $5.27K as of Q3 2026.
ACT Advisors sold 14,549 Mangoceuticals shares in Q3 2026, an estimated $6.45K.
Mangoceuticals made up ﹤0.01% of ACT Advisors's portfolio in Q3 2026, its #85 holding.
ACT Advisors first reported a position in Mangoceuticals in Q2 2026 and has held it in 2 quarters since.
ACT Advisors's Mangoceuticals position peaked at $10.2K in Q2 2026.
2 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2026.

Based on ACT Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.